Thursday, September 25, 2014

Top 5 Dividend Companies To Buy For 2015

Top 5 Dividend Companies To Buy For 2015: Smith & Nephew SNATS Inc.(SNN)

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the orthopaedics, endoscopy, and advanced wound management sectors worldwide. The company operates in three segments: Orthopaedics, Endoscopy, and Advanced Wound Management. The Orthopaedics segment offers reconstruction implants, including hip, knee, and shoulder joints, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. This segment also provides trauma fixation products consisting of internal and external devices, and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures; and clinical therapies products comprising bone growth stimulation, joint fluid therapies, and outpatient spine products. The Endoscopy segment develops and commercializes minimally invasive surgery techniques, educational programs, and value-added services for sur geons to treat and repair soft tissue and articulating joints. It offers specialized devices and fixation systems to repair damaged tissues; fluid management equipment for surgical access; digital cameras, digital image capture, scopes, light sources, and monitors to assist with visualisation; radiofrequency wands, electromechanical and mechanical blades, and hand instruments for resecting damaged tissues. The Advanced Wound Management segment provides initial wound bed preparation and full wound closure products. This segment?s products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, including burns and invasive surgery. The company serves medical and surgical service providers. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.

Advisors' Opinion:
  • [By Charles Carlson! , CEO and Portfolio Manager, Horizon Investment Services]

    For investors looking for growth but also income, I especially like three health-care related stocksFresenius Medical (FMS), Novo Nordisk (NVO), and Smith & Nephew (SNN).

  • [By Jake L'Ecuyer]

    Top Headline
    Smith & Nephew PLC (NYSE: SNN) announced its plans to buy ArthroCare (NASDAQ: ARTC) for $1.7 billion in cash. Smith & Nephew will pay $48.25 per share in cash to acquire ArthroCare, representing a 6.3% premium to ArthroCare's closing price on January 31.

  • [By Royston Wild]

    LONDON -- Shares inSmith & Nephew (LSE: SN  ) (NYSE: SNN  ) have risen steadily in recent months, and were recently up 11% in the year to date.

  • [By James Brumley]

    All that being said, while St. Jude Medical might have never been known as a device pioneer, the acquisitions of Nanostim and Endosense have given STJ stock holders some exposure to pacemakers without pesky leads (where the “pulse” is created), and exposure to atrial fibrillation treatment without the use of drugs. This year might mark a serious upgrade for the company’s product lines.

    Medical Devices: Smith & Nephew plc (SNN)

    Priced at a trailing P/E of 24 and a forward-looking P/E of 17, it’s not like you can call Smith & Nephew plc (SNN) a screaming value. It’s a reliable growth machine, however, in terms of earnings as well as revenue.

  • source from Top Penny Stocks For 2015:http://www.topstocksforum.com/top-5-dividend-companies-to-buy-for-2015-2.html

No comments:

Post a Comment